May 4, 2020 / 12:11 PM / a month ago

BRIEF-Aridis Pharmaceuticals Enrolls First Covid-19 Patient In Ongoing Phase 3 AR-301 Clinical Trial

May 4 (Reuters) - Aridis Pharmaceuticals Inc:

* ARIDIS PHARMACEUTICALS ENROLLS ITS FIRST COVID-19 PATIENT IN ONGOING PHASE 3 AR-301 CLINICAL TRIAL IN VENTILATOR ASSOCIATED PNEUMONIA (VAP)

* ARIDIS PHARMACEUTICALS INC - AR-301 PHASE 3 CLINICAL STUDY EXPECTED TO ENROLL 240 PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below